Treatment Protocols for Ophthalmia Neonatorum: Specific Regulations

Based on Section 3.2.4, Subsection 3.2, Section 3 of the guidelines for diagnosis and treatment of Gonorrhea (Issued together with Decision 5165/QD-BYT in 2021), the specific treatment regimen for gonococcal ophthalmia in newborns is as follows:

Treatment of conjunctivitis caused by gonorrhea in newborns, choose one of the following regimens:

- Ceftriaxone 50 mg/kg (maximum 150 mg), intramuscular single dose

- Kanamycin 25 mg/kg (maximum 75 mg), intramuscular single dose

- Spectinomycin 25 mg/kg (maximum 75 mg), intramuscular single dose.

* Note: Monitor for any adverse drug reactions.

1. b) Prophylactic treatment of conjunctivitis due to gonorrhea and Chlamydia for all newborns immediately after birth and for both eyes. Choose one of the following regimens:

- Tetracycline hydrochloride 1% eye ointment

- Erythromycin 0.5% eye ointment

- Povidone-iodine 2.5% solution (aqueous solvent)

- Silver nitrate 1% solution

- Chloramphenicol 1% eye ointment

* Note: Avoid touching the eyes while applying the medication. The use of povidone-iodine alcohol solvent solution is not recommended.

Respectfully!